Ludwig Hantson, CEO at ALEXION PHARMACEUTICALS INC (ALXN), bought 10,000 shares at $116.72 ($1.2M) on 2017-06-14, disclosed to the SEC on 2017-06-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALXN | SELL | 2018-01-04 | $621K | — | Filing → |
| BAX | SELL | 2014-07-11 | $1.9M | — | Filing → |
| BAX | SELL | 2013-01-29 | $710K | — | Filing → |